Exosomal protein deficiencies: how abnormal RNA metabolism results in childhood-onset neurological diseases
Exosomal protein deficiencies: how abnormal RNA metabolism results in childhood-onset neurological diseases
批准号:
MR/N025431/2
负责人:
Rita Horvath
金额:
$29.74万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
所有的基因都被复制成短寿命的RNA分子,然后被翻译成蛋白质,形成体内细胞的构建盒。DNA的转录、pre-mRNA加工成成熟mRNA(剪接)、mRNA的降解和翻译成蛋白质都受到严格的调控。某种RNA种类过多或过少对细胞都可能是危险的,但我们对微调RNA数量的机制的理解仍然有限。基因表达的调节(RNA代谢)对正常细胞功能至关重要,但神经细胞似乎无法应对错误。越来越多的婴儿或儿童严重的遗传性神经系统疾病是由RNA生产机制的缺陷引起的,这说明了这一点;这些疾病的特点是大脑和中枢神经系统的发育和/或结构异常。本提案的目的是研究和表征一种新型的RNA相关神经系统疾病,这种疾病是由一种称为人类外泌体的多蛋白复合物的功能障碍引起的。外泌体的作用包括RNA的降解和成熟。外显子亚基基因EXOSC3的突变在脑干和小脑的婴儿期变性和脊髓运动神经元功能障碍引起的肌肉无力患者中有报道。我们最近在患有类似严重神经系统疾病的婴儿中发现了EXOSC8的突变,该突变编码人类外泌体的另一个组成部分。此外,这些孩子还失去了大脑和脊髓中的髓磷脂,而髓磷脂通常是包裹和隔离神经的,并起到加速信号传递的作用。我们还在一名患有严重脊髓运动神经元功能障碍的儿童中发现了一种新基因RBM7的纯合突变。RBM7是人类外泌体的相互作用伙伴。这些儿童的严重和孤立的神经系统症状提出了外泌体在神经元中特别重要的可能性;然而,仍有许多悬而未决的问题。本提案的目的是进一步表征外泌体在神经细胞中的作用,并将解决以下几个方面:1。来自患者的神经细胞:我们将分析患者来源的皮肤细胞中的RNA水平,并将用最近发表的方法将其转化为神经细胞。我们将通过不同细胞类型的外泌体的变化来确定哪些RNA物种被修饰。2. 转基因斑马鱼:与此同时,我们将创建斑马鱼外泌体蛋白缺乏模型。通过人工去除单个外泌体成分并在斑马鱼胚胎中引入突变,我们将探索其对大脑和不同类型神经元的发育和功能的影响。此外,我们还将研究修饰外泌体对斑马鱼髓磷脂形成的影响。我们的研究结果将确定外泌体在调节基因表达中的最重要作用,以及为什么它对神经元的损害更大。结合人类细胞和斑马鱼的数据将使我们能够更好地定义外泌体的重要基因和相互作用的伙伴。通过修饰外泌体成分或一些本文确定的相互作用因子,我们可能会发现改变神经元中RNA降解或加工的潜在途径,这可以进一步发展为外泌体疾病或其他类型的由异常RNA功能引起的神经退行性疾病的治疗方法。
英文摘要
All genes are copied into short-lived RNA molecules, which are then translated to protein, forming the building box of the cells in the body. The transcription of DNA, the processing of pre-mRNA into mature mRNA (splicing), the degradation of mRNA and the translation into proteins are all tightly regulated. Both too much and too little of a certain RNA species could be dangerous for a cell, but our understanding of the mechanisms to fine-tune the RNA amounts is still limited. The regulation of gene expression (RNA metabolism) is of utmost importance for normal cell function, nerve cells, however, seem less able to cope with errors. This is illustrated by an increasing number of severe inherited neurological diseases of infancy or childhood caused by a defect in the RNA production machinery; these disorders are characterized by abnormalities of the development and/or the structure of the brain and the central nervous system. The aim of this proposal is to study and characterize a novel form of RNA related neurological disorder due to dysfunction of a multi-protein complex called the human exosome. The role of the exosome consists of degradation and maturation of RNA. Mutations in the exosome subunit gene EXOSC3 were reported in patients with infantile-onset degeneration of the brainstem and cerebellum and muscle weakness due to spinal motor neuron dysfunction. We have recently identified mutations in EXOSC8, encoding another component of the human exosome, in infants with a similar severe neurological disease. In addition, these children also lose myelin in the brain and spinal cord, which normally coats and insulates nerves and serves to speed up signalling. We also identified a homozygous mutation in a novel gene RBM7 in a child with severe spinal motor neuron dysfunction. RBM7 is an interacting partner of the human exosome. The severe and isolated neurological symptoms in these children raise the possibility that the exosome is particularly important in neurons; however, there are still many open questions. The aim of this proposal is to further characterize the role of the exosome in nerve cells and will address the following aspects:1. Neuronal cells from patients: We will analyse RNA levels in patient derived skin cells and will transform them into neuronal cells with recently published methods. We will determine which RNA species are modified by changes in the exosome in the different cell types. 2. Genetically modified zebrafish: In parallel, we will create zebrafish models of exosomal protein deficiencies. By artificially removing single exosome components and by introducing mutations in zebrafish embryos we will explore its effect on the development and function of the brain and different types of neurons. In addition, we will also study the effect of modifying the exosome on myelin formation in zebrafish. Our results will identify the most important roles of the exosome in regulating gene expression and why is it more damaging for neurons. Combining the data in human cells and zebrafish will enable us to better define the important genes and interacting partners of the exosome. By modifying exosome components or some of the here identified interacting factors we may discover potential pathways to alter RNA degradation or processing in neurons, which can be further developed as a therapeutic approach in exosomal diseases or in other types of neurodegenerative diseases caused by abnormal RNA function.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders.
EURO-NMD 注册中心:联合 FAIR 基础设施、创新技术和以患者为中心的罕见神经肌肉疾病注册中心概念。
DOI:
10.1186/s13023-024-03059-3
发表时间:
2024
期刊:
Orphanet journal of rare diseases
影响因子:
3.7
作者:
[Atalaia A]
通讯作者:
Atalaia A
DOI:
10.1056/nejmoa2035790
发表时间:
2021-11-11
期刊:
The New England journal of medicine
影响因子:
--
作者:
[100,000 Genomes Project Pilot Investigators, Smedley D, Smith KR, Martin A, Thomas EA, McDonagh EM, Cipriani V, Ellingford JM, Arno G, Tucci A, Vandrovcova J, Chan G, Williams HJ, Ratnaike T, Wei W, Stirrups K, Ibanez K, Moutsianas L, Wielscher M, Need A, Barnes MR, Vestito L, Buchanan J, Wordsworth S, Ashford S, Rehmström K, Li E, Fuller G, Twiss P, Spasic-Boskovic O, Halsall S, Floto RA, Poole K, Wagner A, Mehta SG, Gurnell M, Burrows N, James R, Penkett C, Dewhurst E, Gräf S, Mapeta R, Kasanicki M, Haworth A, Savage H, Babcock M, Reese MG, Bale M, Baple E, Boustred C, Brittain H, de Burca A, Bleda M, Devereau A, Halai D, Haraldsdottir E, Hyder Z, Kasperaviciute D, Patch C, Polychronopoulos D, Matchan A, Sultana R, Ryten M, Tavares ALT, Tregidgo C, Turnbull C, Welland M, Wood S, Snow C, Williams E, Leigh S, Foulger RE, Daugherty LC, Niblock O, Leong IUS, Wright CF, Davies J, Crichton C, Welch J, Woods K, Abulhoul L, Aurora P, Bockenhauer D, Broomfield A, Cleary MA, Lam T, Dattani M, Footitt E, Ganesan V, Grunewald S, Compeyrot-Lacassagne S, Muntoni F, Pilkington C, Quinlivan R, Thapar N, Wallis C, Wedderburn LR, Worth A, Bueser T, Compton C, Deshpande C, Fassihi H, Haque E, Izatt L, Josifova D, Mohammed S, Robert L, Rose S, Ruddy D, Sarkany R, Say G, Shaw AC, Wolejko A, Habib B, Burns G, Hunter S, Grocock RJ, Humphray SJ, Robinson PN, Haendel M, Simpson MA, Banka S, Clayton-Smith J, Douzgou S, Hall G, Thomas HB, O'Keefe RT, Michaelides M, Moore AT, Malka S, Pontikos N, Browning AC, Straub V, Gorman GS, Horvath R, Quinton R, Schaefer AM, Yu-Wai-Man P, Turnbull DM, McFarland R, Taylor RW, O'Connor E, Yip J, Newland K, Morris HR, Polke J, Wood NW, Campbell C, Camps C, Gibson K, Koelling N, Lester T, Németh AH, Palles C, Patel S, Roy NBA, Sen A, Taylor J, Cacheiro P, Jacobsen JO, Seaby EG, Davison V, Chitty L, Douglas A, Naresh K, McMullan D, Ellard S, Temple IK, Mumford AD, Wilson G, Beales P, Bitner-Glindzicz M, Black G, Bradley JR, Brennan P, Burn J, Chinnery PF, Elliott P, Flinter F, Houlden H, Irving M, Newman W, Rahman S, Sayer JA, Taylor JC, Webster AR, Wilkie AOM, Ouwehand WH, Raymond FL, Chisholm J, Hill S, Bentley D, Scott RH, Fowler T, Rendon A, Caulfield M]
通讯作者:
Caulfield M
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome
撰写罕见疾病治疗系统评价以生成符合 FAIR 标准的数据集的指南:构建 Treatabolome
DOI:
10.17863/cam.56498
发表时间:
2020
期刊:
影响因子:
--
作者:
[Atalaia A]
通讯作者:
Atalaia A
DOI:
10.1002/mgg3.500
发表时间:
2018-11
期刊:
Molecular genetics & genomic medicine
影响因子:
2
作者:
[Abicht A, Scharf F, Kleinle S, Schön U, Holinski-Feder E, Horvath R, Benet-Pagès A, Diebold I]
通讯作者:
Diebold I
DOI:
10.1212/wnl.0000000000005566
发表时间:
2018-05-22
期刊:
Neurology
影响因子:
9.9
作者:
[Bansagi B, Phan V, Baker MR, O'Sullivan J, Jennings MJ, Whittaker RG, Müller JS, Duff J, Griffin H, Miller JAL, Gorman GS, Lochmüller H, Chinnery PF, Roos A, Swan LE, Horvath R]
通讯作者:
Horvath R
Medicine Made to Measure
-
批准号:EP/Y032470/1
-
项目类别:Research Grant
-
资助金额:$33.22万
-
财政年份:2024
-
负责人:Rita Horvath
-
依托单位:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
-
批准号:MR/V009346/1
-
项目类别:Research Grant
-
资助金额:$114.71万
-
财政年份:2021
-
负责人:Rita Horvath
-
依托单位:
New genomic approaches to explore the neurogenetic disease burden of consanguineous marriages in Turkey
-
批准号:MR/N027302/2
-
项目类别:Research Grant
-
资助金额:$9.38万
-
财政年份:2018
-
负责人:Rita Horvath
-
依托单位:
New genomic approaches to explore the neurogenetic disease burden of consanguineous marriages in Turkey
-
批准号:MR/N027302/1
-
项目类别:Research Grant
-
资助金额:$32.3万
-
财政年份:2016
-
负责人:Rita Horvath
-
依托单位:
Exosomal protein deficiencies: how abnormal RNA metabolism results in childhood-onset neurological diseases
-
批准号:MR/N025431/1
-
项目类别:Research Grant
-
资助金额:$71.16万
-
财政年份:2016
-
负责人:Rita Horvath
-
依托单位:
Molecular mechanism of the recovery in infantile reversible cytochrome c oxidase (COX) deficiency myopathy
-
批准号:G1000848/1
-
项目类别:Research Grant
-
资助金额:$50.62万
-
财政年份:2011
-
负责人:Rita Horvath
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: